Novavax said the Food and Drug Administration allowed it to continue testing a combination COVID-19-flu and standalone flu vaccine that had been put on hold.

Novavax. The FDA has approved the Novavax COVID-19 vaccine for people 12 years and older. This vaccine offers another option for those who haven’t gotten the Pfizer, Moderna, or J&J vaccine.

Novavax can move forward with a trial ... Meanwhile, Moderna said last week that it plans to file for FDA approval of its own combo vaccine by the end of the year. Write to Ben Glickman at ben ...

Novavax shares dropped Tuesday morning after the company slashed its full-year outlook when it announced its third-quarter results.

This summary covers recent significant events in the health sector, including major deals, court decisions, new drug ...

It was later granted full FDA approval in August 2021 for people ... or nausea throughout the rest of the body. Novavax: The Novavax was the fourth COVID vaccine to be administered in the U.S ...

Vernon Bernardino has given his Buy rating due to a combination of factors including the recent clearance by the FDA ... (CIC) vaccine. This approval signifies that Novavax has satisfactorily ...

Novavax sells Czech manufacturing facility to Novo Nordisk for $200 million, aiming to cut costs by $80 million annually and ...

Recently, the FDA has placed a clinical hold ... Earlier in October, the European Commission approved Novavax's updated 2024-2025 Nuvaxovid COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2705 ...

Novavax said the Food and ... COVID-19-flu and standalone flu vaccines. The company explained that the U.S. Food and Drug Administration (FDA) removed its clinical hold on the studies, and will ...

Novavax can move forward with a trial ... Meanwhile, Moderna said last week that it plans to file for FDA approval of its own combo vaccine by the end of the year.